JPRN-UMIN000020513已完成2 期
MR-CHOP therapy (high dose MTX with R-CHOP) for primary CNS lymphoma. - MR-CHOP for PCNS
Department of hematology and Immunology, Kanazawa Medical University0 个研究点目标入组 20 人开始时间: 2016年1月9日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, extra CNS lesions 2, severe infectious disease 3, history of chemotherapy for lymphoma 4, HIV+, HTLV1+, HBs-Ag+ 5, judgement as inappropriate to inclusion to this study by physician
研究者
相似试验
已完成
2 期
Prospective study of high dose MTX with R-CHOP therapy for primary central nervous system lymphoma.Primary CNS lymphoma (CD20+ diffuse large B-cell lymphoma)JPRN-UMIN000001343Hematology and Immunology, Kanazawa Medical University10
进行中（未招募）
2 期
Phase II study of R-CHOP and R-high-dose MTX therapy for IVLBCJPRN-jRCTs041180165Yamaguchi Motoko37
进行中（未招募）
不适用
Treatment with R-MegaCHOP and early rescue with R-IFE and autologous stem cells transplant (ASCT) according response measured by positron emission tomography (PET) in patients with diffuse large B-cell lymphoma (DLBCL) with severe prognosis. - GEL/TAMO-2006Diffuse Large B-Cell Lymphoma (DLBCL)EUCTR2006-005254-68-ESGEL/TAMO (Cooperative Spanish Group of Lymphoma/Autologous bone marrow transplant).
招募中
不适用
Dose-escalation with MR-guided stereotactic radiotherapy in isolated malignancies in the upper abdomen (RADIOPANC): a phase I dose finding trialNL-OMON52302niversitair Medisch Centrum Utrecht18
尚未招募
不适用
Treatment with high dose Methotrexate in patients with generalized eosinophilic fasciitisShulman's syndrome or diffuse fasciitis10010761NL-OMON30014niversitair Medisch Centrum Sint Radboud6